Technical Tweaks

A blog post notes that technical issues have been beleaguering Oxford Nanopore.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

I think it is to ONP's credit

I think it is to ONP's credit that they turned off the hype. If Pac Bio had done such, much of the $700+M they raised could have gone to more productive uses in funding other promising companies instead of building out an international sales organization 4 levels deep for instance. Its easy for someone new to the tools business to over estimate the performance of their product and underestimate what the real world problems will be. Those of us who have been through the process before should know better.

//I think it is to ONP's

//I think it is to ONP's credit that they turned off the hype.// On the other hand, they had plenty of hype to turn off. In the absence of data to support the claims they made at AGBT a year ago...

I think they've done 1, 20min

I think they've done 1, 20min talk in 6 years, hardly 'hype'.